Table 1.
AT | CH | DE | ES | IT | LT | NL | PL | |
---|---|---|---|---|---|---|---|---|
Male | 23.4 | 32.8 | 37.5 | 27.3 | 23.2 | 14.5 | 27.8 | 19.6 |
Occupational | 24.5 | 21.1 | 41.2 | 15.9 | 23.6 | 19.7 | 18.6 | 35.9 |
Atopic eczema | 24.5 | 17.8 | 26.4 | 9.1 | 11.2 | 7.4 | 34.7 | 9.3 |
Site of ACD: Hand | 34.8 | 29.3 | 45.7 | 24.9 | 38.2 | 26.2 | 22.3 | 26.7 |
Site of ACD: Leg | 9.2 | 8.7 | 10.0 | 7.3 | 2.7 | 9.5 | 2.9 | 5.5 |
Site of ACD: Face | 20.3 | 26.0 | 16.4 | 12.1 | 12.6 | 27.1 | 20.9 | 13.3 |
Age ≥40 y | 62.8 | 66.5 | 71.8 | 65.8 | 39.0 | 61.2 | 63.3 | 58.0 |
Total (n) | 282 | 1002 | 981 | 1375 | 259 | 461 | 1293 | 602 |
Abbreviations: AT, Austria; CH, Switzerland; DE, Germany; ES, Spain; IT, Italy; LT, Lithuania; NL, The Netherlands; PL, Poland.
All figures are percentages. Note that the three sites (hand, leg, and face) do not relate to the primary site of contact dermatitis (irrespective of other information such as diagnosis or patch test reactions) normally used for the MOAHLFA index, but to the same single sites used elsewhere in this analysis.
P‐value of χ 2 test for heterogeneity across countries: P < 0.0001 for all MOAHLFA items.